Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Syncona Partners LLP

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 45
Average round size
info
The average size of a deal this fund participated in
$54M
Portfolio companies 22
Rounds per year 3.75
Lead investments 18
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.51
Exits 6
Key employees 11

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Biopharma
Summary

In 2012 was created Syncona Partners LLP, which is appeared as VC. The venture was found in Europe in United Kingdom. The main office of represented VC is situated in the London.

The overall number of key employees were 11.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Syncona Partners LLP, startups are often financed by UCL Technology Fund, Sixth Element Capital, Woodford Investment Management. The meaningful sponsors for the fund in investment in the same round are UCL Technology Fund, UCLB, Sixth Element Capital. In the next rounds fund is usually obtained by Woodford Investment Management, UCL Technology Fund, Sequoia Capital.

Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019. This Syncona Partners LLP works on 17 percentage points less the average amount of lead investments comparing to the other organizations. The typical startup value when the investment from Syncona Partners LLP is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Gyroscope Therapeutics, Cambridge Epigenetix, Quell Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Syncona Partners LLP:
Typical Co-investors
Syncona Partners LLP is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Syncona Partners LLP:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Akana by Perforce Minneapolis, Minnesota, United States
Chasing Value Asset Management -
Conversion Capital New York, New York, United States
Dada Entertainment New York, New York, United States
Darling Ventures California, San Francisco, United States
Global Health Innovative Technology Fund Karachi, Pakistan, Sindh
Mantella Venture Partners Canada, Ontario, Toronto
Nazem and Company New York, New York, United States
Peterson Ventures Salt Lake City, United States, Utah
Pixta Japan, Tokyo
Quasar Builders Argentina, Buenos Aires, Distrito Federal
Rice Warner -
Sanmei Touzi China, Guangdong, Guangzhou
SVIC Japan, Shizuoka, Shizuoka Prefecture
SWFI Las Vegas, Nevada, United States
Tiny VC California, San Francisco, United States
Vertex Partners Japan, Tokyo
Zhejiang Culture Industry Growth Fund -
Zoho California, Pleasanton, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Purespring Therapeutics

Biotechnology
Medical
09 Oct 2024 London, England, United Kingdom

Resolution Therapeutics

Biopharma
Biotechnology
Drug Discovery
Life Science
03 Oct 2024 London, England, United Kingdom

Yellowstone Biosciences

$22M20 Jun 2024 Oxford, Oxfordshire, United Kingdom

Beacon Therapeutics

Health Care
Therapeutics
$170M03 Jun 2024 London, England, United Kingdom

Beacon Therapeutics

Health Care
Therapeutics
$131M12 Jun 2023 London, England, United Kingdom

Mosaic Therapeutics

Medical
Therapeutics
$28M04 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

SwanBio Therapeutics

Biotechnology
$56M18 May 2022 Lower Merion Township, Pennsylvania, United States

OMass Technologies

Life Science
Pharmaceutical
$103M27 Apr 2022 Oxford, England, United Kingdom

Resolution Therapeutics

Biopharma
Biotechnology
Drug Discovery
Life Science
$13M05 Apr 2022 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Syncona Partners LLP?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 45
Average round size 54M
Rounds per year 3.75
Peak activity year 2019
Lead investments 18
Follow on index 0.51
Exits 6
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Purespring Therapeutics

Biotechnology
Medical
09 Oct 2024 London, England, United Kingdom

Resolution Therapeutics

Biopharma
Biotechnology
Drug Discovery
Life Science
03 Oct 2024 London, England, United Kingdom

Yellowstone Biosciences

$22M20 Jun 2024 Oxford, Oxfordshire, United Kingdom

Beacon Therapeutics

Health Care
Therapeutics
$170M03 Jun 2024 London, England, United Kingdom

Beacon Therapeutics

Health Care
Therapeutics
$131M12 Jun 2023 London, England, United Kingdom

Mosaic Therapeutics

Medical
Therapeutics
$28M04 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

SwanBio Therapeutics

Biotechnology
$56M18 May 2022 Lower Merion Township, Pennsylvania, United States

OMass Technologies

Life Science
Pharmaceutical
$103M27 Apr 2022 Oxford, England, United Kingdom

Resolution Therapeutics

Biopharma
Biotechnology
Drug Discovery
Life Science
$13M05 Apr 2022 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: